Comparative review of pharmacological therapies in individuals with HER2 positive advanced breast cancer with focus on hormone receptor subgroup.

M. Umemneku-Chikere, Chinyereugo, Ayodele, Olubukola, Soares, Marta O orcid.org/0000-0003-1579-8513 et al. (4 more authors) (2022) Comparative review of pharmacological therapies in individuals with HER2 positive advanced breast cancer with focus on hormone receptor subgroup. Frontiers in Oncology. ISSN 2234-943X

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2022 Umemneku-Chikere, Ayodele, Soares, Khan, Abrams, Owen and Bujkiewicz.
Dates:
  • Accepted: 22 July 2022
  • Published: 18 August 2022
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York)
Depositing User: Pure (York)
Date Deposited: 25 Jul 2022 15:10
Last Modified: 14 Jan 2024 00:18
Published Version: https://doi.org/10.3389/fonc.2022.943154
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.3389/fonc.2022.943154

Downloads

Accepted Version

Filename: Revised_Manuscript_Untracked_version.pdf

Description: Revised Manuscript Untracked version

CLICK TO DOWNLOAD [img]

Published Version

Filename: fonc_12_943154.pdf

Description: Comparative review of pharmacological therapies in individuals with HER2-positive advanced breast cancer with focus on hormone receptor subgroups

Licence: CC-BY 2.5

CLICK TO DOWNLOAD [img]

Export

Statistics


CORE (COnnecting REpositories)